Preface

Our goal is to offer our patients , referring physicians as well as respondents a high-tech laboratory platform to support efforts to treat  the cancer patients in a personal way according to the individual risk and predicted drug sensitivity. In the awareness e of the pronounced molecular individuality of cancerous diseases we have pooled knowledge, experience and state-of-the-art technologies enabling a reliable, trustful molecular characterization of individual malignant tumors thus paving the way for an optimized cancer therapy.